You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,881,200


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,881,200
Title: Needleless syringe using super sonic gas flow for particle delivery
Abstract:A needleless syringe having a membrane (28) which is ruptured by gas pressure to generate a supersonic gas flow in which particles containing a therapeutic agent are injected.
Inventor(s): Bellhouse; Brian J. (Islip, GB), Sarphie; David F. (Oxford, GB), Greenford; John C. (Abingdon, GB)
Assignee: PowderJect Research Limited (Oxford, GB)
Application Number:09/248,743
Patent Claim Types:
see list of patent claims
Dosage form; Delivery;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,881,200: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article will delve into the details of United States Patent 6,881,200, focusing on its claims, scope, and the broader patent landscape.

Patent Overview: US 6,881,200

Patent Title and Description

United States Patent 6,881,200, titled "Needleless syringe using supersonic gas flow for particle delivery," is a utility patent that describes a method and device for delivering particles, such as drugs or vaccines, through the skin using supersonic gas flow. This technology is designed to replace traditional needle-based delivery methods, offering a pain-free and potentially more efficient alternative.

Patent Owner and History

The patent was originally assigned to PowderJect Pharmaceuticals Inc., a company that has since been involved in various mergers and acquisitions. Understanding the current ownership and any changes in ownership is essential for determining the patent's current status and any potential licensing or enforcement activities[2].

Claims Analysis

Independent and Dependent Claims

The patent includes a set of independent and dependent claims that define the scope of the invention. Independent claims are the broadest claims and define the core of the invention, while dependent claims narrow down the scope by adding additional limitations.

  • Independent Claim 1: This claim typically describes the overall invention, including the key components and their functions. For example, it might claim a "needleless syringe comprising a gas chamber, a nozzle, and a particle container, where the gas chamber is configured to generate a supersonic gas flow to deliver particles through the skin."
  • Dependent Claims: These claims build upon the independent claims by adding specific details or limitations. For instance, a dependent claim might specify the material of the nozzle or the type of particles being delivered.

Claim Scope and Interpretation

The scope of the claims determines what is protected by the patent. It is essential to analyze each claim to understand what is covered and what is not. This involves interpreting the claim language in the context of the specification and any relevant prior art.

  • Claim Charts: Tools like ClaimScape® software can help in visualizing and analyzing the claim coverage. These charts can be reviewed by technical experts to determine if a particular product or method falls within the scope of the claims[3].

Patent Landscape

Related Patents and Family Patents

Understanding the broader patent landscape involves identifying related patents and family patents. This includes patents filed in other countries and those that cover similar technologies.

  • Global Dossier: Utilizing services like the Global Dossier can provide access to file histories of related applications from participating IP Offices. This helps in identifying the patent family and understanding the global protection of the invention[4].

Exclusivities and Patent Expiry

Patent exclusivities and expiry dates are critical for determining when generic versions of the drug or similar technologies can enter the market.

  • Expiry Date: The patent expiry date for US 6,881,200 has already passed, as indicated by the patent details. This means that the technology described in the patent is no longer protected by this specific patent[2].
  • Exclusivities: While the patent may have expired, any exclusivities granted by regulatory bodies like the FDA could still be in effect. However, for US 6,881,200, any such exclusivities would have expired long ago[2].

Legal Activities and Updates

Maintenance Fees and Legal Actions

Tracking recent legal activities on the patent, such as maintenance fee payments, office actions, and any amendments or terminations, is vital.

  • Maintenance Fees: For US 6,881,200, since the patent has expired, no further maintenance fees are required. However, historical records of such payments can provide insights into the patent's lifecycle[2].
  • Office Actions: Reviewing office actions and other legal activities can help in understanding any challenges or disputes related to the patent during its active period[4].

International Protection

Patent Protection in Other Countries

The protection of the invention is not limited to the United States. It is essential to look at the broader international patent landscape.

  • Family Patents: Identifying family patents filed in other countries helps in understanding the global scope of protection. Tools like the Global Dossier and international patent databases can facilitate this search[4].

Competitive Analysis

Identifying Gaps and Opportunities

Conducting a competitive analysis involves identifying gaps in the current patent coverage and potential future design opportunities.

  • Claim Coverage Matrix: Using a Claim Coverage Matrix can help in categorizing patents by claims and scope concepts, making it easier to identify areas where there is a lack of coverage or potential for innovation[3].

Practical Applications and Market Impact

Market Entry Strategies

Understanding the patent landscape and the scope of the claims can inform market entry strategies for companies looking to develop similar technologies.

  • Generic Launch: For drugs or technologies protected by patents like US 6,881,200, understanding when the patent expires and any exclusivities that may still be in effect is crucial for planning a generic launch[2].

Tools and Resources for Patent Analysis

USPTO Resources

The USPTO provides several resources for patent analysis, including the Patent Public Search tool, Global Dossier, and the Patent Examination Data System (PEDS).

  • Patent Public Search: This tool offers enhanced access to prior art and can be used to search for existing patents and published patent applications[4].
  • Global Dossier: This service provides access to file histories of related applications from participating IP Offices, helping in the analysis of the global patent landscape[4].

Conclusion

Analyzing the scope and claims of United States Patent 6,881,200 involves a detailed examination of the patent's claims, the broader patent landscape, and any relevant legal activities. Given that the patent has expired, the focus shifts to understanding the historical context and how similar technologies might be protected or challenged in the future.

Key Takeaways

  • Patent Claims: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Patent Landscape: Identifying related patents and family patents helps in understanding the global protection of the invention.
  • Exclusivities and Expiry: Tracking exclusivities and patent expiry dates is essential for market entry strategies.
  • Legal Activities: Monitoring legal activities such as maintenance fees and office actions provides insights into the patent's lifecycle.
  • International Protection: Looking at the broader international patent landscape is vital for comprehensive analysis.

FAQs

What is the current status of US Patent 6,881,200?

US Patent 6,881,200 has expired, meaning the technology described is no longer protected by this patent.

How do I determine if a product falls within the scope of a patent claim?

Using tools like Claim Charts and analyzing the claim language in the context of the specification and prior art can help determine if a product falls within the scope of a patent claim.

What is the significance of maintenance fees for patents?

Maintenance fees are payments required to keep a patent in force. For expired patents like US 6,881,200, no further maintenance fees are required.

How can I search for related patents and family patents?

Tools like the Global Dossier and international patent databases can help in identifying related patents and family patents.

What are exclusivities, and how do they affect generic market entry?

Exclusivities granted by regulatory bodies can delay the generic launch of a drug or technology, even after the patent has expired. However, for US 6,881,200, any such exclusivities would have expired long ago.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,881,200

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,881,200

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9307459Apr 08, 1993
United Kingdom9318407Sep 06, 1993
United Kingdom9321356Oct 15, 1993

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.